Rhythm Pharmaceuticals Inc (RYTM)
SG&A Expense Growth
6.07%
Quarterly · Period ending:
RYTM SG&A Expense Growth
Latest reported6.07%period ending
Latest reported6.07%period ending
RYTM Quarterly SG&A Growth (QoQ) (0.00% → 6.07%)
Latest values, visible window
High-resolution chart · PNG
RYTM sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 6.0653% | |
| 10.6296% | |
| 9.6422% | |
| 14.101% | |
| 17.5506% | |
| 2.5098% | |
| 7.7819% | |
| -2.8505% | |
| 5.913% | |
| 6.2025% | |
| 6.2313% | |
| 1.4278% | |
| 21.9696% | |
| -6.3951% | |
| 19.9608% | |
| -1.7467% | |
| 4.0981% | |
| 2.1527% | |
| 19.9349% | |
| 13.204% | |
| 6.5229% | |
| 10.6639% | |
| 16.2105% | |
| 26.5441% | |
| -30.2829% | |
| 35.9252% | |
| -10.6407% | |
| 19.1607% | |
| 13.9451% | |
| -7.4988% | |
| -1.7684% | |
| 32.655% | |
| 36.5217% | |
| 8.8915% | |
| 87.041% | |
| 70.5969% | |
| -10.4881% | |
| -44.7522% | |
| 179.4297% | |
| -11.77% | |
| -24.3886% | |
| -27.3086% | |
| 119.6312% | |
| 285.7741% | |
| 0% | |
| 67.1329% | |
| -53.4202% | |
| -19.5282% | |
| 0% | |
| 0% | |
| 0% |